000			01862 a2200481 4500
005			20250515205040.0
264		0	_c20100512
008			201005s 0 0 eng d
022			_a1091-6490
024	7		_a10.1073/pnas.0914879107 _2doi
040			_aNLM _beng _cNLM
100	1		_aJordan, Kimberly R
245	0	0	_aPeptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cMar 2010
300			_a4652-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntigens, Neoplasm _ximmunology
650	0	4	_aCancer Vaccines _xadministration & dosage
650	0	4	_aCell Line
650	0	4	_aCell Line, Tumor
650	0	4	_aColorectal Neoplasms _ximmunology
650	0	4	_aCytotoxicity, Immunologic _ximmunology
650	0	4	_aFemale
650	0	4	_aHistocompatibility Antigens Class I _ximmunology
650	0	4	_aImmunodominant Epitopes _ximmunology
650	0	4	_aInterferon-gamma _xmetabolism
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Transgenic
650	0	4	_aPeptide Library
650	0	4	_aReceptors, Antigen, T-Cell _ximmunology
650	0	4	_aSpodoptera
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aVaccination
650	0	4	_aVaccines, Subunit _xadministration & dosage
700	1		_aMcMahan, Rachel H
700	1		_aKemmler, Charles B
700	1		_aKappler, John W
700	1		_aSlansky, Jill E
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 107 _gno. 10 _gp. 4652-7
856	4	0	_uhttps://doi.org/10.1073/pnas.0914879107 _zAvailable from publisher's website
999			_c19505465 _d19505465